India’s emergence as a hub for affordable medicines is commendable: Dr. Jitendra Singh
We now rank 3rd in pharmaceutical production by volume and 14th by value
We now rank 3rd in pharmaceutical production by volume and 14th by value
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
The conference aims to bring various stakeholders and experts in the field of healthcare and digital solutions for ensuring ‘universal access to affordable and quality healthcare’
PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service
He advocated for a "PPP + PPP" collaboration, urging the public and private sectors within India to partner with their counterparts in other countries
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated